Search results for "Anticoagulation"
Score may help determine safe anticoagulation with warfarin in patients with liver disease
A 4-point score may help clinicians determine which patients with chronic liver disease can safely receive warfarin, a new study reports.
https://immattersacp.org/weekly/archives/2014/05/20/6.htm
20 May 2014
New oral anticoagulants may slightly decrease all-cause mortality when compared to warfarin, meta-analysis suggests
In patients with atrial fibrillation, the advantages of all 4 new oral anticoagulants over warfarin seem to outweigh the risks, a new meta-analysis found.
https://immattersacp.org/weekly/archives/2013/12/10/6.htm
10 Dec 2013
Use of warfarin down, DOACs up in commercially insured patients with cirrhosis, nonvalvular afib
While more than half of eligible patients with cirrhosis and concurrent nonvalvular atrial fibrillation did not receive anticoagulation between 2012 and 2019, use of direct oral anticoagulants (DOACs) increased substantially during that time, a recent study found.
https://immattersacp.org/weekly/archives/2023/01/17/4.htm
17 Jan 2023
DOACs may be safe, effective for VTE prevention in patients with higher weight, BMI
Patients with first-time venous thromboembolism (VTE) who weighed 120 kg or more and had a body mass index (BMI) of 40 kg/m2 or more were not at higher risk for bleeding or recurrent VTE with direct-acting oral anticoagulants (DOACs) versus warfarin.
https://immattersacp.org/weekly/archives/2021/11/09/4.htm
9 Nov 2021
Pros, cons of prolonged anticoagulation after a clot
Experts debate about provoked vs. unprovoked venous thromboembolism, and whether a once-high-risk patient can have that status removed later.
https://immattersacp.org/archives/2020/02/pros-cons-of-prolonged-anticoagulation-after-a-clot.htm
1 Feb 2020
Updated Beers criteria highlight medications that are risky in older patients
The American Geriatrics Society has added warfarin as a medication to avoid and urged caution with sodium-glucose cotransporter-2 inhibitors in the latest update of its guidance on prescribing for U.S. adults ages 65 years and older.
https://immattersacp.org/weekly/archives/2023/05/16/1.htm
16 May 2023
Aspirin appears to reduce recurrence of VTE after stopping anticoagulants
Aspirin reduced the risk of venous thromboembolism (VTE) recurrence with no apparent increase in major bleeding in patients who had an initial unprovoked VTE and had discontinued anticoagulant treatment, a study found.
https://immattersacp.org/weekly/archives/2012/06/05/6.htm
5 Jun 2012
DOACs more effective, cost-effective than LMWH for cancer-associated thrombosis
A meta-analysis compared three direct oral anticoagulants (DOACs) (apixaban, edoxaban, and rivaroxaban) to low-molecular-weight heparin (LMWH) and found that apixaban was usually the most cost-effective option, but that finding hinged on the specific drug price.
https://immattersacp.org/weekly/archives/2023/01/03/5.htm
3 Jan 2023
Managing DOACs in primary care
Primary care physicians play a crucial role in ongoing anticoagulation management, including educating patients about the signs of venous thromboembolism.
https://immattersacp.org/archives/2022/04/managing-doacs-in-primary-care.htm
1 Apr 2022
Tailoring anticoagulation more of a reality with DOACs
Direct oral anticoagulants have the potential to replace warfarin for the treatment of many patients with venous thromboembolism, but without a need for routine monitoring, good patient selection is key to their use.
https://immattersacp.org/archives/2018/03/tailoring-anticoagulation-more-of-a-reality-with-doacs.htm
1 Mar 2018